Edwards Lifesciences (EW) Short-term Investments (2011 - 2026)

Edwards Lifesciences' Short-term Investments history runs 16 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• In Q1 2026, Short-term Investments rose 61.76% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (up 61.76% YoY), while the FY2025 annual figure was $1.3 billion, up 38.42% from the prior year.
• Short-term Investments was $1.2 billion for Q1 2026 at Edwards Lifesciences, down from $1.3 billion in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $1.3 billion in Q4 2025 to a low of $317.7 million in Q2 2022.
• Historically, Short-term Investments has averaged $662.3 million across 5 years, with a median of $490.9 million in 2022.
• Biggest YoY gain for Short-term Investments was 197.31% in 2022; the steepest drop was 26.11% in 2022.
• A 5-year view of Short-term Investments shows it stood at $446.3 million in 2022, then gained by 12.14% to $500.5 million in 2023, then surged by 85.95% to $930.7 million in 2024, then jumped by 38.42% to $1.3 billion in 2025, then slipped by 4.84% to $1.2 billion in 2026.
• The last three Short-term Investments figures came in at $1.2 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.